Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Mol Cancer Ther. 2021 Jun 4;20(8):1388–1399. doi: 10.1158/1535-7163.MCT-20-0591

Figure 1.

Figure 1.

Profiling of cytokine/chemokine produced from CMG, LM8, and NFSa cell lines.

A. Cytokine/chemokine production in the culture supernatant tested by cytokine array. a. G-CSF; b., GM-CSF; c. I-309 (CCL-1); d. Eotaxin (CCL11); e. IFN-γ; f. IL-6; g. IL-7; h. IL-17; i. IP-10 (CXCL-10); j. I-TAC (CXCL-11); k. KC (CXCL-1); l. CSF-1; m. JE (CCL-2); n. MIG (CXCL-9); o. MIP-2 (CXCL-2); p. RANTES (CCL5); q. SDF-1 (CXCL12); r. TIMP-1. B. Concentration of cytokines/chemokines in CMG, TCM/LM8, and TCM/NFSa, evaluated by the signal intensity shown in A.